Fig. 2From: Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectumThe BACCHUS trial. Patients will be randomised to one of two neoadjuvant chemotherapy regimensBack to article page